Oramed Appoints Dr. Julio Rosenstock to Its Scientific Advisory Board
NEW YORK, Jan. 30, 2020 /PRNewswire/ — Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, today announced the addition of Dr. Julio Rosenstock to its Scientific Advisory Board. Dr. Rosenstock is the current Director of the Dallas Diabetes Research Center […]
